These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36080200)

  • 41. Synthesis, characterization and irradiation enhances anticancer activity of liposome-loaded iridium(III) complexes.
    Tian S; Nie Q; Chen H; Liang L; Hu H; Tang S; Yang J; Liu Y; Yin H
    J Inorg Biochem; 2024 Jul; 256():112549. PubMed ID: 38579631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis and biological evaluation of iridium(III) complexes as potential antitumor agents.
    Du F; Bai L; He M; Zhang WY; Gu YY; Yin H; Liu YJ
    J Inorg Biochem; 2019 Dec; 201():110822. PubMed ID: 31536949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
    Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
    Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
    Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
    Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
    Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brominated cyclometalated iridium(III) complexes for mitochondrial immobilization as potential anticancer agents.
    Liu B; Chen Z; Li Y; Du XF; Zhang W; Zhang W; Lai Y; Li Y
    Dalton Trans; 2022 May; 51(19):7650-7657. PubMed ID: 35510904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ligand Dictated Photosensitization of Iridium(III) Dithiocarbamate Complexes for Photodynamic Therapy.
    Negi M; Dixit T; Venkatesh V
    Inorg Chem; 2023 Dec; 62(49):20080-20095. PubMed ID: 37994001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents.
    Wu Y; Liu J; Shao M; Zhang P; Song S; Yang G; Liu X; Liu Z
    J Inorg Biochem; 2022 Aug; 233():111855. PubMed ID: 35576884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
    J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, characterization, molecular docking, RNA-sequence and anticancer efficacy evaluation in vitro of ruthenium(II) complexes on B16 cells.
    Huang C; Zhang H; Yang Y; Liu H; Chen J; Wang Y; Liang L; Hu H; Liu Y
    J Inorg Biochem; 2023 Oct; 247():112329. PubMed ID: 37478780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, and antitumor mechanism investigation of iridium(III) complexes conjugated with ibuprofen.
    Chen SQ; Lu XY; Zhu LY; Zhu H; Li RT; Ye RR
    J Inorg Biochem; 2024 Aug; 257():112596. PubMed ID: 38759264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel heterobimetallic Ir(III)-Re(I) complexes: design, synthesis and antitumor mechanism investigation.
    Lu JJ; Ma XR; Xie K; Yang PX; Li RT; Ye RR
    Dalton Trans; 2022 May; 51(20):7907-7917. PubMed ID: 35535974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of substituents on DNA and protein binding of cyclometalated Ir(iii) complexes and anticancer activity.
    Mukhopadhyay S; Singh RS; Paitandi RP; Sharma G; Koch B; Pandey DS
    Dalton Trans; 2017 Jul; 46(26):8572-8585. PubMed ID: 28640302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Iridium(III)-Cp*-(imidazo[4,5-
    Kar B; Shanavas S; Nagendra AH; Das U; Roy N; Pete S; Sharma S A; De S; Kumar S K A; Vardhan S; Sahoo SK; Panda D; Shenoy S; Bose B; Paira P
    Dalton Trans; 2022 Apr; 51(14):5494-5514. PubMed ID: 35293923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In Vitro and In Vivo Antitumor Assay of Mitochondrially Targeted Fluorescent Half-Sandwich Iridium(III) Pyridine Complexes.
    Wang L; Liu X; Wu Y; He X; Guo X; Gao W; Tan L; Yuan XA; Liu J; Liu Z
    Inorg Chem; 2023 Feb; 62(8):3395-3408. PubMed ID: 36763897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Iridium(III) complexes conjugated with naproxen exhibit potent anti-tumor activities by inducing mitochondrial damage, modulating inflammation, and enhancing immunity.
    Xie K; Lu XY; Zhu H; Zhu LY; Li RT; Ye RR
    Dalton Trans; 2024 May; 53(20):8772-8780. PubMed ID: 38712840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Iridium (III) complex-loaded liposomes as a drug delivery system for lung cancer through mitochondrial dysfunction.
    Liao C; Xu D; Liu X; Fang Y; Yi J; Li X; Guo B
    Int J Nanomedicine; 2018; 13():4417-4431. PubMed ID: 30104875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring anticancer efficiency of mitochondria-targeted cyclometalated iridium(III) complexes.
    Gu Y; Wen H; Bai L; Zhou Y; Zhang H; Tian L; Zhang Y; Hao J; Liu Y
    J Inorg Biochem; 2020 Nov; 212():111215. PubMed ID: 32919250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New iridium bis-terpyridine complexes: synthesis, characterization, antibiofilm and anticancer potentials.
    Sahin C; Mutlu D; Nasirli F; Mahmoudi G; Zubkov FI; Arslan S; Dogan NM
    Biometals; 2021 Jun; 34(3):701-713. PubMed ID: 33900533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.